EWTX - Edgewise Therapeutics Inc (Healthcare: Biotechnology) Projected Earnings Date: 0000-02-29    (Delayed quote data   2025-04-04)
Last
 11.51		 Change
 ⇓ -2.07   (-15.24%)		 Volume
  4,454,356
Open
 12.67		 High
 13.28		 Low
 11.50
8EMA (Daily)
 17.61		 40EMA (Daily)
 23.61		 50EMA (Daily)
 24.29		 STO (Daily)
 8.301		 MACD Hist (Daily)
 -2.541
8EMA (Weekly)
 22.388		 40EMA (Weekly)
 24.45		 50EMA (Weekly)
 23.58		 STO (Weekly)
 16.966		 MACD Hist (Weekly)
 -3.234
Company Profile
Edgewise Therapeutics Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development and commercialization of innovative treatments for severe, rare muscle disorders. It is developing orally bioavailable, small molecule therapies for musculoskeletal diseases.
optionchance optionchance
⇒ Home | Chart and Research | Education | About Us  

Disclaimer: All information provided is for informational purposes only and not intended for trading purposes or advice. The quotes and charts are not real time and have delays of at least 20 minutes. Data accuracy cannot be guaranteed as errors will occur. Please do not rely on the above information to make your stock/option trades. Neither OptionChance.com nor any of independent data providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.

Questions or Comments: support@optionchance.com
Copyright © 2025 OptionChance.com